Mk-7684
Drug Oncology
General payments
$178,180
Research payments
$7,751,454
Through program year 2020, $178,180 in general payments and $7,751,454 in research payments were reported against Mk-7684 (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $74,425 | 36 |
| 2020 | Research | $3,428,063 | 2,189 |
| 2019 | General | $103,755 | 29 |
| 2019 | Research | $4,323,391 | 313 |
Breakdown
Each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
65 general · 2,502 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.